These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2005-003409-98 Enhancement by tacrolimus of nerve regeneration after peripheral nerve repair. not-yet-due
Ongoing, reported early 2005-004288-47 Etude des effets d'un antagoniste calcique(la barnidipine) sur la sensibilité des chémorécepteurs et l'activité orthosympathique. not-yet-due
Ongoing 2005-004460-22 Multicenter, pilot, open, randomized, parallel group study to evaluate the association of Neoral with ACE-inhibitors as compared to corticosteroids with ACE-inhibitors in the treatment of de novo neph... not-yet-due
Ongoing 2005-004469-40 Multicenter, pilot, open, randomized, parallel group study to evaluate the association of Neoral with ACE-inhibitors as compared to ACE-inhibitors alone in the treatment of de novo nephrotic syndrome ... not-yet-due
Ongoing 2005-004607-11 Prospective, randomized, long-term study compairing a Neoral (C-0h monitoring)-based steroid-free to an everolimus-myfortic based, calcineurin-inhibitor-free immunosuppressive treatment on graft funct... not-yet-due
Ongoing 2005-004685-17 A prospective placebo controlled study of botulilium toxin (BOTOX) on gait disorder induced by spastic equinovarus foot. not-yet-due
Not reported 2006-001765-42 A prospective and randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with new-onset diabetes mellitus after renal transplantation (REVERSE study... 2015-04-17 due-trials
Ongoing 2006-001806-94 Comparison of the efficacy of pneumococcal and tetanus vaccination between hemodialysis patients and renal tranpslant recipients treated with Mycophenolic acid(VACC-IR) study. not-yet-due
Reported results 2006-001945-32 Introduction of everolimus is associated with a reduction in the dosage of calcineurine-inhibitors in patients with a pulmonary graft who suffer from a notable chronic renal insuffisance. 2008-02-29 due-trials
Reported results 2006-003133-33 Etude des effets d’un antagoniste non spécifique de l’endothéline (le bosentan) sur l’activité orthosympathique et le chémoréflexe. 2011-12-30 due-trials
Ongoing 2006-003318-16 Prise en charge de l'hyperalgésie en salle de soins post-anesthésie: role de la ketamine et de la clonidine not-yet-due
Ongoing, reported early 2006-004066-14 Etude des effets de l'enoximone sur la sensibilité du chémorécepteur. not-yet-due
Reported results 2006-004720-37 Effect of Voluven on postoperative morbidity after gynaecological surgery 2009-04-03 due-trials
Reported results 2006-006944-78 Evaluation du bénéfice de survie lors de l'adjonction de pentoxifylline à la corticothérapie dans l'hépatite alcoolique sévère 2011-01-11 due-trials
Ongoing 2007-004580-21 3T versus 1.5 T MR cholangiography using Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic acid (Primovist) not-yet-due
Ongoing 2007-005289-11 A non randomized , stratified phase II trial evaluating efficacy and safety of oxaliplatin in combination with 5-Fluorouracil in patients with platinum-sensitive and platinum-resistant recurrent ovari... not-yet-due
Completed, but no date, and reported results 2008-000551-10 Randomised Phase II study of biweekly versus fractionated triweekly combination Taxotere-Cisplatin-5FU in advanced gastric and gastro-esophageal junction cancer bad-data
Ongoing 2008-002387-33 Impact of 25-hydroxy vitamin D deficiency and its correction on mineral and bone disorde among hemodialysis patients not-yet-due
Ongoing 2008-003621-16 Utilisation du sufentanil en péridural lors du travail obstétrical: étude des répercussions sur le nouveau-né et l'allaitement maternel not-yet-due
Reported results 2008-004278-41 A phase II study of doxorubicin, cyclophosphamide and vindesine with valproic acid in patients with refractory or relapsing small cell lung cancer after platinum derivatives and etoposide. 2013-11-29 due-trials
Reported results 2008-007712-14 Monitoring of serum concentrations of posaconazole given as prophylaxis or therapy. 2010-08-31 due-trials
Not reported 2009-009467-59 Feasibility study of hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with stage III or only pleural stage IV ovarian carcinoma in first line therapy. 2015-09-27 due-trials
Completed, report not yet due 2009-011445-13 Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer 2023-11-27 not-yet-due
Ongoing 2009-014050-15 Conversion from a twice-daily tacrolimus (tac) regimen to a once-daily tacorlimus exended-release formulation (TacXL) regimen : Pharamcokinetic studies in stable cystic fibrosis (CF) and non-CF patien... not-yet-due
Reported results 2009-014346-28 Timing of intubation in a modified rapid sequence induction with remifentanil 2009-12-31 due-trials
Ongoing 2009-015402-19 Chimiothérapie d’induction suivie d’une radiochimiothérapie préopératoire à base de cisplatine, 5FU et panitumumab dans le traitement des cancers oesogastriques avancés et opérables not-yet-due
Ongoing 2009-016082-29 Role of Lanreotide in the Management of Paraduodenal Pancreatitis not-yet-due
Reported results 2009-017350-13 Pharmacokinetics of oseltamivir in patients with infection due to influenza A H1N1 2009 admitted in intensive care unit. 2013-07-15 due-trials
Completed, but no date, and reported results 2010-023695-91 Sorafenib plus capecitabine activity assesment in patients with advanced pre-treated colorectal cancer bad-data
Ongoing 2011-001573-10 optimization of doses of broad spectrum B-lactames (ceftazidim and meropenem) and vancomycin in septic patient traeted with chronic hemodialysis. not-yet-due
Ongoing 2011-002985-19 An open-label phase II trial evaluating the efficacy and safety of neoadjuvant EndoTAGTM-1 in combination with paclitaxel in patients with Her2-negative high risk breast cancer not-yet-due
Reported results 2011-004070-29 What are the optimal doses of cephalosporins of first and second generation to manage obese patients? Quelles sont les doses optimales de céphalosporines de premières et deuxième génération à admin... 2013-07-12 due-trials
Exempt 2011-004144-22 A Phase I/II study to assess the safety and immunogenicity of WT1-A10 + AS01B Antigen-Specific Cancer Immunotherapeutic (ASCI) combined with infusions of ex vivo regulatory T cells depleted T lymphocy... not-yet-due
Reported results 2011-004239-29 what are the optimal doses of broad spectrum B-lactams to administer to obese patients if infected? 2012-09-28 due-trials
Completed, report not yet due 2011-005437-39 A phase II prospective imaging study evaluating the utility of pre-treatment zirconium-89 labelled trastuzumab PET/CT and an early FDG-PET/CT response to identify patients with advanced HER-2 positiv... 2024-03-28 not-yet-due
Exempt 2011-005474-38 89Zr-Rituximab PET/CT-Imaging and Dosimetry and 90Y-Rituximab Radioimmunotherapy in CD20+ B-Cell lymphoma not-yet-due
Not reported 2011-006224-21 A pre-operative window study evaluating Denosumab, a RANK-Ligand (RANKL) inhibitor and its biological effects in young pre-menopausal women diagnosed with early breast cancer 2017-01-06 due-trials
Ongoing 2011-006259-12 Phase II study on prospective evaluating the quantification of total choline by magnetic resonance spectroscopy (MRS) in breast tumours as an early predictive marker of neoadjuvant chemotherapy respon... not-yet-due
Reported results 2011-006280-21 Correlating the tumoral metabolic progression index measured by serial FDG PET-CT and apparent diffusion coefficient measured by MRI to patient's outcome in advance colorectal cancer 2021-09-25 due-trials
Ongoing 2012-003412-31 Efficiency and Safety of Ovarian Stimulation with Letrozole for fertility preservation in breast cancer patients. Etude de l'efficacité et de l'innocuité des stimulations ovariennes avec du letrozo... not-yet-due
Not reported 2012-003516-31 Evaluation of tumoral perfusion modification by dynamic imaging after neoadjuvant chemotherapy combining gemcitabine and a Hedgehog inhibitor (Vismodegib) in patients with resectable pancreatic adenoc... 2016-05-03 due-trials
Not reported 2012-003592-19 Evaluation of tumoral perfusion modification by dynamic imaging after chemotherapy combining gemcitabine and nab-paclitaxel (Abraxane) in patients with potentially operable, locally advanced or metast... 2017-04-30 due-trials
Not reported 2012-003666-41 The LuMEn study 177Lu-octreotate treatment outcome prediction using Multimodality imaging in refractory neuroEndocrine tumours 2022-09-16 due-trials
Ongoing 2012-003857-26 The Bacteriuria In Renal Transplantation study: A prospective, randomized, multicenter trial comparing antibiotics versus no treatment in the prevention of urinary tract infection in kidney transplant... not-yet-due
Ongoing 2012-004031-23 Serum pharmacokinetics of Caspofungin in patients with liver failure. not-yet-due
Reported results 2012-004860-22 The [PEARL] Study : Pet imaging as a biomarker of Everolimus Added value in hormone Refractory postmenopausaL women 2021-07-05 due-trials
Completed, but no date, and reported results 2012-005194-32 A phase II trial evaluating Cabazitaxel in patients with brain metastasis secondary to breast and non-small-cell lung cancer bad-data
Completed, but no date, and reported results Terminated 2012-005545-20 The CaStOR study Carcinoid Tumors after failure of Somatostatin analogs: a randomized phase III of Octreotide Lutate Peptid Receptor radionuclide Therapy (PRRT) versus inteRferon α-2b bad-data
Ongoing 2012-005626-30 Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced (non resectable) and metastatic cholangiocarcinoma: a randomized double-blinded phase II trial. Evalua... not-yet-due
Reported results 2012-005655-16 Regorafenib Assessment in Refractory advanced Colorectal cancer 2018-01-26 due-trials
Ongoing 2013-000100-41 Histological study of the (intravenously injected) Indocyanine Green (ICG) distribution in tumour bearing breasts and in axillary pieces of dissection not-yet-due
Completed, but no date, and reported results Terminated 2013-000173-77 TRIUMPH Trial A phase II TRial evalUating the Menstrual and ovarian function of young breast cancer patients treated with a cycloPHosphamide-free regimen composed of doxorubicin and paclitaxel bad-data
Ongoing 2013-000276-15 Feasibility study of the (intravenously injected) Indocyanine green (ICG) imaging of tumoral implants in patients with peritoneal carcinomatosis from ovarian carcinoma not-yet-due
Ongoing 2013-000652-18 Pharmacokinetics study of piperacillin-tazobactam and meropenem in obese patients not-yet-due
Ongoing 2013-000653-42 Feasibility study of the (intravenously injected) ICG imaging of tumoral implants in patients with peritoneal carcinomatosis from colorectal cancer not-yet-due
Ongoing 2013-001360-36 Evaluation of the benefit of lymphofluoroscopy in the validation of the manual drainage techniques on lymphedema Evaluation de l'intérêt de la lymphofluoroscopie dans la validation des techniques d... not-yet-due
Ongoing 2013-001555-12 Evaluation of Near-Infra-Red Imaging after peri-areolar and subcutaneous injections of ICG in comparison with the lymphoscintigraphic technique using intra-mammary and peri-tumoral injection of 99mTc-... not-yet-due
Ongoing 2013-002079-16 Pharmacokinetics of Caspofungin after one dose in patients with liver failure. not-yet-due
Ongoing 2013-003349-41 what are the optimal doses of cefuroxime for cirrhotic patients? Quelles sont les doses optimales de cefuroxime à administrer chez les patients obèses? not-yet-due
Ongoing 2013-004496-12 Study of the (intravenously injected) ICG distribution in tumour bearing breasts and in axillary pieces of dissection of patients who have received neo-adjuvant therapy for histologically proven mamma... not-yet-due
Ongoing 2013-004498-29 Near-Infrared fluorescence imaging during neck dissection in head and neck cancer patients after intravenous injection of Indocyanine Green (a feasibility study) Imagerie en fluorescences infraro... not-yet-due
Reported results 2013-004607-39 Safety of preoperative administration of hemin to reduce the risk of acute kidney injury after on-pump cardiac surgery: a pilot randomised study in double blind. 2017-07-25 due-trials
Ongoing 2013-004705-59 Monocentric phase III clinical trial using citalopram (antidepressive compound fequently used in clinic) added to the standard of care (radio- combined with temozolomide chemotherapy and followed by t... not-yet-due
Ongoing 2013-004987-80 Colistin use in Cystic Fibrosis patients: pharmacokinetic studies (intravenous administration) in relation with pharmacodynamics, tolerance profile and risk of selection of resistance. not-yet-due
Ongoing 2013-005178-23 Study of the (intravenously injected) Indocyanine Green distribution in the margins of breast cancer after tumorectomy not-yet-due
Ongoing 2014-000298-37 Near-Infrared fluorescence imaging during neck dissection in head and neck cancer patients after peritumoral injection of Indocyanine Green (a feasibility study) not-yet-due
Ongoing 2014-002119-41 Influence of a new model of relative hypoxia on the evolution of erythropoietin and haemoglobin in patients undergoing breast reconstruction by a Deep Inferior Epigastric Perforator Flap. not-yet-due
Ongoing 2014-002501-38 The occlusion pressure of superficial lymphatics in the upper extremity of healthy volunteers: A Near infrared lymphofluoroscopy approach not-yet-due
Ongoing 2014-003268-19 Study evaluating breast cancer tumorectomy guided by Near-Infrared imaging after the intravenous injection of free Indocyanine Green not-yet-due
Ongoing 2014-003512-37 Study of the (intravenously injected) ICG (Indocyanine Green) imaging of tumoral implants in patients with peritoneal carcinomatosis from colorectal origin. not-yet-due
Ongoing 2014-003598-41 Pilot study of incretin analogs as new therapeutics for Friedreich's Ataxia. not-yet-due
Completed, but no date, and reported results Terminated 2014-004358-32 Biomarker Research Study for PF-03084014 in cHEmoresistant triple negative breast cAncer - “RHEA” study bad-data
Ongoing 2014-004393-41 A double-blind, placebo-controlled study of the impact of prophylactic treatment with Galantamine 8mg of cognitive impairment during an electroconvulsive therapy (ECT) in patients with major depressi... not-yet-due
Ongoing 2015-001809-14 Beta-Lactams (ceftazidime, piperacilline-tazobactam, meropenem) dosing scheme validation in septic hemodialysed patient not-yet-due
Ongoing 2015-003708-22 Colistin use in critically ill patients: pharmacokinetic population and pharmacodynamic studies, tolerance profil and risk of selection of resistance not-yet-due
Completed, report not yet due 2015-004618-10 Study of the inter-individual variation of PhArmaCo-kinetics of InFliximab during treatment Induction in patients with Crohn’s disease and Ulcerative Colitis 2023-08-16 not-yet-due
Completed, but no date, and reported results 2015-005574-38 The DESIGN trial A randomised, Double-blind, placEbo-controlled Study to assess the effectIveness of pectoral nerves block (Pecs) after breast surGery on Piritramide coNsumption. bad-data
Ongoing 2015-005685-30 Evaluation of microcirculation alterations in cardiac surgery, by FMD (Flow Mediated vasoDilation), Near Infrared Spectrophotometry (NIRS) and biological analysis Evaluation des altérations de la m... not-yet-due
Completed, but no date, and reported results Terminated 2016-000842-79 Prospective evaluation of 68Ga-PSMA PET-CT for Recurrence detection of Prostate Cancer and its impact on patient management The ProsPERo Trial bad-data
Not reported 2016-000879-24 Neoadjuvant Biomarker ResearcH Study of Palbociclib Combined with Endocrine Therapy in Estrogen Receptor Positive/ HER2 Negative Breast CAncer 2023-02-01 due-trials
Exempt, with results 2016-000935-42 Assessment of Metabolic and pathological Response to Treatment with Radio-chemotherapy (RCT) and Immunotherapy (ImT) before Surgery in locally advanced Esophageal and gastro-esophageal junction cancer... 2017-12-11 not-yet-due
Reported results Terminated 2016-004398-41 Multicentre, non-randomised, open-label, single agent phase II study to determine the clinical benefit of trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer patients with brain me... 2018-08-27 due-trials
Ongoing 2016-005136-16 Corticosteroids in patients with severe alcoholic hepatitis patients in early spontaneous improvement Traitement aux corticostéroïdes chez des patients ayant une hépatite alcoolique sévère et qui m... not-yet-due
Completed, report not yet due 2017-000123-28 Multiorgan Metabolic imaging response assessment of Abemaciclib: the MiMe-A trial 2023-12-11 not-yet-due
Ongoing 2017-002758-35 Avelumab as neoadjuvant therapy in subjects with urothelial muscle invasive bladder cancers not-yet-due
Exempt 2017-004651-23 A Phase I/II Study of Paclitaxel plus Carboplatin and Durvalumab (MEDI4736) with or without Oleclumab (MEDI9447) for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple-negative Bre... not-yet-due
Ongoing 2017-005074-19 Minimal optimal dose of Sugammadex during ambulatory surgery in dentistry Dose minimale optimale de sugammadex lors d’une chirurgie ambulatoire de stomatologie not-yet-due
Ongoing 2018-004165-13 Neo-adjuvant chemotherapy combined with SBRT to the primary tumour +/- durvalumab (MEDI4736), +/- oleclumab in luminal B breast cancer: a phase ll randomized trial not-yet-due
Ongoing 2018-004512-22 Effect of dexmedetomidine vs 0.9% sodium chloride on Nol-Index guided remifentanil analgesia: a double-blinded bicenter randomized controlled trial not-yet-due
Ongoing 2019-001077-87 Patient reported outcomes in term of swallowing and quality of life after prophylactic versus reactive percutaneous endoscopic gastrostomy tube placement in advanced head and neck cancer patients trea... not-yet-due
Ongoing 2019-004942-14 Neoadjuvant study of targeting ROS1 in combination with endocrine therapy in invAsive Lobular carcINoma of the breast not-yet-due
No trial status on register 2020-000714-15 Phentolamines and their role in everyday dentistry Les phentolamines et leur impact dans la dentisterie au quotidien. bad-data
Reported results 2020-000824-21 An open label phase II study to evaluate neratinib for treatment and prevention of subsequent CNS event(s) in patients with brain metastasis of advanced HER2 positive breast cancer 2021-11-24 due-trials
Ongoing 2020-000876-40 A phase II trial of neoadjuvant REGorafenib in combination with nIvolumab and short-course radiotherapy iN stage II-III rectAl cancer not-yet-due
Ongoing 2020-001085-11 Pre-operative evaluation by [18F]-JK PSMA-7 PET/CT in intermediate and high-risk prostate cancer patients, candidates for radical prostatectomy with curative intent: a pilot study L’évaluation préo... not-yet-due
Listed as ongoing, but also has a completion date 2020-002918-41 De-Escalation of neoadjuvant ChemotheRapy in HER2-positive, EStrogen reCEptor-negative, Node-negative early breast cancer patients who achieved pathological complete response after neoadjuvant chemoth... 2023-10-02 bad-data
Ongoing 2021-000412-28 COVID-19: Sars-Cov2 vaccination in kidney transplant patient: a phase IV study of the immunogenicity and its determinants not-yet-due
Ongoing 2021-000461-33 Covid-19: Sars-Cov2 vaccination in hemodialysis patient: a phase IV study of the immunogenicity and its determinants not-yet-due
Listed as ongoing, but also has a completion date 2021-003710-39 COVID-19 : Immune response in patients with cancer undergoing vaccination against SARS-CoV-2 2024-01-08 bad-data
Ongoing 2021-003760-27 INCENTIVE-QIV-3-EU: Immunogenicity, molecular profiling of a marketed quadrivalent influenza vaccine (Vaxigrip Tetra®) administered by the intramuscular route in participants aged 6 to 8 months not-yet-due
No trial status on register 2022-002697-80 Maternal determinants of infant immunity to pertussis bad-data